Opportunity Information: Apply for CDC RFA GH12 1247
Apply for CDC RFA GH12 1247
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Cooperative Agreement with the Chinese Center for Disease Control and Prevention" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on May 17, 2012 and posted on May 17, 2012.
- Applicants must submit their applications by Jun 22, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $50,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $10,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Applicants Assistance will only be provided to the Chinese Center for Disease Control (China CDC). No other applications are solicited. China CDC is the most appropriate and qualified agency to conduct the activities specified under this cooperative agreement for the following reasons 1. China CDC is the only organization in China that possesses the requisite public health, scientific and technical expertise and the infrastructure capacity, and who has the primary responsibility within the Chinese government to address public health issues. These combined attributes make it uniquely qualified as the only organization in China capable of effectively conducting the activities proposed for this umbrella cooperative agreement. 2. China CDC is uniquely positioned in terms of governmental authority, mandate and ability to oversee and safeguard public health, and to collect and analyze information and disseminate reports related to multiple health issues. It has the ability to utilize existing public health networks and other partners to assure the accomplishment of public health goals as required in this cooperative agreement. 3. China CDC has in place the central, provincial and district based structures required to immediately engage in the activities listed in this announcement. 4. China CDC is the key governmental agency that will enable U.S. CDC to execute its approved global health strategy. Specifically, U.S. CDC working through its strong partnerships with China CDC, will assure the implementation and evaluation of public health programs that will result in the prevention and control of diseases both communicable and non communicable in China. 5. Over the past 10 years with two consecutive influenza cooperative agreements as well as one emerging infectious disease agreement and two HIV/AIDS agreements, China CDC has strengthened field epidemiology training programs, influenza surveillance and control programs, emerging infections programs, TB surveillance programs, HIV/AIDS prevention, care, training and surveillance programs, and has scaled up successful pilot projects. China CDC has achieved goals and accomplished objectives that have lead to improving the heath and quality of life of Chinese citizens. Furthermore, China CDC has shared advances in research and lessons learned in the public health practice with U.S. CDC and the rest of the world
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Cooperative Agreement with the Chinese Center for Disease Control and Prevention (China CDC) is a Centers for Disease Control and Prevention (U.S. CDC) discretionary funding opportunity designed to support large-scale public health work in China through a single cooperative agreement. The initiative is organized around four overarching goals: putting proven disease prevention and control interventions into practice, applying established public health tools, identifying disease-control efforts with broader global relevance, and expanding workforce training and institutional capacity. In practical terms, the opportunity is meant to strengthen national systems that detect health threats, evaluate them through epidemiology and laboratory science, and translate findings into effective programs and policies.
Program activities focus heavily on building and improving national public health surveillance, epidemiologic assessment, and laboratory and diagnostic capacity. The scope is broad and includes both communicable and non-communicable health priorities, with an emphasis on HIV/AIDS. The HIV-related work explicitly includes areas such as blood safety, injection safety, infection control, and medical waste management, alongside prevention, care, training, and surveillance. Other infectious disease priorities include malaria, tuberculosis, influenza, and other diseases with pandemic potential, as well as emerging and re-emerging infections and neglected tropical diseases. Beyond infectious diseases, the agreement also supports work in environmental health, chronic diseases, maternal and child health, reproductive health, public health preparedness, biosafety, and injury prevention and control. The intent is to use evidence-based approaches, improve data quality and diagnostic capability, and implement programs that measurably reduce illness, premature death, and impacts on quality of life.
A major component of the award is training and capacity building across the public health workforce. The agreement supports training opportunities for laboratory personnel, China CDC staff, and selected university and graduate-level students, as well as other implementers involved in public health programs. Training topics include health assessment and epidemiology, evidence-based program planning, program implementation and evaluation, and data collection and analysis. It also includes operational skills needed to run large programs effectively, such as personnel management and financial and administrative management, reflecting the expectation that capacity gains will be sustainable and embedded in routine operations.
Institutionally, the cooperative agreement aims to strengthen China CDC’s ability to plan, implement, and evaluate evidence-based public health programs, and to expand its capacity to conduct surveillance and epidemiologic analyses that inform disease prevention and control at national and regional levels. Another key expectation is that evaluation results will not remain academic or isolated; they are intended to be fed back into day-to-day disease control operations, shared across China and internationally, and used to help develop science-based health policies and guidelines. This makes the award as much about improving decision-making systems and policy translation as it is about individual disease projects.
From an administrative and funding standpoint, this opportunity (Funding Opportunity Number: CDC RFA GH12-1247) was posted May 17, 2012, with an application closing date of June 22, 2012, and an archive date of July 22, 2012. It uses a cooperative agreement funding instrument, which typically implies substantial involvement by the funding agency in collaboration and technical partnership. The activity category is health, CFDA number 93.283 (CDC Investigations and Technical Assistance). The program anticipated a single award, with an estimated total funding amount of $50,000,000 and an annual award range defined by a floor of $50,000 and a ceiling of $10,000,000. There is no cost sharing or matching requirement.
Eligibility is restricted: assistance will only be provided to the Chinese Center for Disease Control and Prevention, and no other applications were solicited. The justification given is that China CDC is uniquely positioned in China with the necessary mandate, authority, infrastructure, and nationwide network (central, provincial, and district levels) to conduct the work described. The announcement also highlights a history of prior cooperative agreements between U.S. CDC and China CDC over roughly a decade, including influenza, emerging infectious diseases, and HIV/AIDS efforts, which reportedly strengthened surveillance, training programs, and the scale-up of successful pilot projects. The opportunity therefore functions as an “umbrella†cooperative agreement intended to consolidate and expand a longstanding bilateral public health partnership while supporting outcomes that matter both for China and for global health security.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is a U.S. Centers for Disease Control and Prevention (U.S. CDC) discretionary funding opportunity to support large-scale public health work in China through a single cooperative agreement with the Chinese Center for Disease Control and Prevention (China CDC).
What is the official funding opportunity number (FON)?
The Funding Opportunity Number is CDC RFA GH12-1247.
What type of funding instrument is being used?
The opportunity uses a cooperative agreement as the funding instrument, which typically involves substantial involvement by the funding agency as a collaborator and technical partner.
Who is the intended recipient of the award?
Eligibility is restricted to the Chinese Center for Disease Control and Prevention (China CDC). No other applications were solicited.
Are other organizations eligible to apply?
No. The announcement states that assistance will only be provided to China CDC, and no other applications were solicited.
Why is eligibility limited to China CDC?
The justification provided is that China CDC is uniquely positioned in China with the necessary mandate, authority, infrastructure, and a nationwide network spanning central, provincial, and district levels to carry out the work described.
How many awards were anticipated?
The program anticipated a single award.
What is the estimated total funding amount?
The estimated total funding amount is $50,000,000.
What is the annual award range?
The annual award range is defined by a floor of $50,000 and a ceiling of $10,000,000.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
When was the opportunity posted?
The opportunity was posted on May 17, 2012.
What was the application closing date?
The application closing date was June 22, 2012.
When was the opportunity archived?
The archive date was July 22, 2012.
What is the activity category?
The activity category is health.
What is the CFDA number associated with this opportunity?
The CFDA number is 93.283, listed as CDC Investigations and Technical Assistance.
What are the overarching goals of the initiative?
The initiative is organized around four goals: (1) putting proven disease prevention and control interventions into practice, (2) applying established public health tools, (3) identifying disease-control efforts with broader global relevance, and (4) expanding workforce training and institutional capacity.
What is the overall purpose of the cooperative agreement in practical terms?
In practical terms, the opportunity is intended to strengthen national systems that detect health threats, evaluate them through epidemiology and laboratory science, and translate findings into effective programs and policies.
What kinds of public health systems and capabilities does the program emphasize?
Program activities focus heavily on building and improving national public health surveillance, epidemiologic assessment, and laboratory and diagnostic capacity.
Does the scope include both communicable and non-communicable health priorities?
Yes. The scope is described as broad and includes both communicable and non-communicable health priorities, with an emphasis on HIV/AIDS.
Which health area is explicitly emphasized?
The opportunity places an explicit emphasis on HIV/AIDS.
What HIV-related activities are included?
HIV-related work explicitly includes blood safety, injection safety, infection control, and medical waste management, alongside prevention, care, training, and surveillance.
What other infectious disease priorities are mentioned?
Other infectious disease priorities include malaria, tuberculosis, influenza, and other diseases with pandemic potential, as well as emerging and re-emerging infections and neglected tropical diseases.
Are non-infectious public health areas included?
Yes. The agreement also supports work in environmental health, chronic diseases, maternal and child health, reproductive health, public health preparedness, biosafety, and injury prevention and control.
What approach does the program intend to use to improve health outcomes?
The intent is to use evidence-based approaches, improve data quality and diagnostic capability, and implement programs that measurably reduce illness, premature death, and impacts on quality of life.
How important is training and capacity building in this award?
Training and capacity building across the public health workforce is described as a major component of the award.
Who can participate in the training supported by the cooperative agreement?
The agreement supports training opportunities for laboratory personnel, China CDC staff, selected university and graduate-level students, and other implementers involved in public health programs.
What training topics are included?
Training topics include health assessment and epidemiology, evidence-based program planning, program implementation and evaluation, and data collection and analysis.
Does the training include operational or management skills?
Yes. It includes operational skills needed to run large programs effectively, such as personnel management and financial and administrative management.
What institutional capabilities is the cooperative agreement intended to strengthen at China CDC?
It aims to strengthen China CDC’s ability to plan, implement, and evaluate evidence-based public health programs, and to expand its capacity to conduct surveillance and epidemiologic analyses that inform disease prevention and control at national and regional levels.
How are evaluation results expected to be used?
Evaluation results are intended to be fed back into day-to-day disease control operations, shared across China and internationally, and used to help develop science-based health policies and guidelines.
Is this award intended to support policy translation and decision-making systems?
Yes. The description emphasizes improving decision-making systems and translating findings into programs, policies, guidelines, and routine operations, not just conducting isolated disease projects.
What is meant by describing this as an "umbrella" cooperative agreement?
It is described as an umbrella cooperative agreement intended to consolidate and expand a longstanding bilateral public health partnership while supporting outcomes relevant to China and to global health security.
What background relationship between U.S. CDC and China CDC is noted?
The announcement highlights roughly a decade of prior cooperative agreements between U.S. CDC and China CDC, including work on influenza, emerging infectious diseases, and HIV/AIDS, which reportedly strengthened surveillance, training programs, and the scale-up of successful pilot projects.
Browse more opportunities from the same category: Health
Next opportunity: Crater Lake National Park Research
Previous opportunity: Cooperative Ecosystem Studies Unit, Great Lakes Northern Forest CESU
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH12 1247
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH12 1247) also looked into and applied for these:
| Funding Opportunity |
|---|
| Building Resilience Against Climate Effects in State, Territorial and Tribal Health Departments Apply for CDC RFA EH12 1202 Funding Number: CDC RFA EH12 1202 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| National Center for Child Traumatic Stress Category I Apply for SM 12 005 Funding Number: SM 12 005 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $6,000,000 |
| Project LAUNCH Apply for SM 12 009 Funding Number: SM 12 009 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $850,000 |
| Research Education Program for Laboratory Animal Medicine Veterinarians (R25) Apply for RFA OD 12 006 Funding Number: RFA OD 12 006 Agency: National Institutes of Health Category: Health Funding Amount: $112,000 |
| PPHF 2012 Viral Hepatitis, Early Identification, and Linkage to Care for Persons with Chronic HBV and HCV Infections Financed Solely by 2012 Prevention and Public Health Fund Apply for CDC RFA PS12 1209PPHF12 Funding Number: CDC RFA PS12 1209PPHF12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Tuberculosis Control Project Apply for RFA 492 12 000002 Funding Number: RFA 492 12 000002 Agency: Agency for International Development Category: Health Funding Amount: $28,300,000 |
| HIV/AIDS Flagship Apply for USAID CAMBODIA RFA 442 12 000003 Funding Number: USAID CAMBODIA RFA 442 12 000003 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $30,000,000 |
| Strengthening HIV/AIDS Services for More at Risk Populations in Papua New Guinea Apply for AID RFA 492 12 000029 Funding Number: AID RFA 492 12 000029 Agency: Philippines USAID Manila Category: Health Funding Amount: $20,000,000 |
| Support for Improvement Science (SIS) Apply for AID OAA A 12 00014 Funding Number: AID OAA A 12 00014 Agency: USAID Category: Health Funding Amount: $185,492,000 |
| Scholarships for Disadvantaged Students (SDS) Apply for HRSA 12 079 Funding Number: HRSA 12 079 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Polio Eradication Project Apply for RFA OAA 12 000019 Funding Number: RFA OAA 12 000019 Agency: Agency for International Development Category: Health Funding Amount: $38,000,000 |
| World Trade Center Health Program Outreach and Education Plan Apply for CDC RFA OH12 1201 Funding Number: CDC RFA OH12 1201 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Connecting Latino and African American Males to Sexual Health Services An Adaptation of Project Connect Apply for CDC RFA PS12 1212 Funding Number: CDC RFA PS12 1212 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| PPHF 2012 Immunization Capacity Building Assistance to Strengthen Public Health Immunization Infrastructure and Performance financed in part by 2012 Prevention and Public Health Funds Apply for CDC RFA IP12 1206PPHF12 Funding Number: CDC RFA IP12 1206PPHF12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $900,000 |
| Addiction Technology Transfer Centers Apply for TI 12 008 Funding Number: TI 12 008 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $765,000 |
| PPHF 2012 Community Transformation Grants Small Communities Programs financed solely by 2012 Prevention and Public Health Funds Apply for CDC RFA DP12 1216PPHF12 Funding Number: CDC RFA DP12 1216PPHF12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Center for Genomic Studies on Mental Disorders (U24) Apply for RFA MH 13 050 Funding Number: RFA MH 13 050 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases (SBIR R43/R44) Apply for PA 12 191 Funding Number: PA 12 191 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| 2012 Title X Family Planning Training and Technical Assistance Cooperative Agreement FOA Part A 2 Management and Systems Improvement Apply for PA FPT 12 012 Funding Number: PA FPT 12 012 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,000,000 |
| 2012 Title X Family Planning Training and Technical Assistance Cooperative Agreement FOA Part A 3 Family Planning Service Delivery Apply for PA FPT 12 013 Funding Number: PA FPT 12 013 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH12 1247", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.